Explore more publications!

Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

Press releases published on October 6, 2025

DPM Metals Responds to Revocation of the Loma Larga Environmental Licence
BPGbio Appoints Veteran Clinical and Commercial Leader Dr. Brian Berman as Interim Chief Medical Officer
Pharming Group provides update on previously announced G&A expense reduction plan
Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters
NEVADA CANYON ANNOUNCES SIGNIFICANT GOLD INTERCEPTS REPORTED AT THE LAPON CANYON GOLD PROJECT
Western Uranium & Vanadium to Acquire Uranium Claims
MAX Power Partners With PRmediaNow to Expand Global Reach and Accelerate Natural Hydrogen Leadership
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
WALKER RIVER ANNOUNCES SIGNIFICANT GOLD INTERCEPTS AT THE LAPON GOLD PROJECT 
Critical Metals Corp Signs $35 million PIPE With a New Fundamental Institutional Investor
NorthWest Announces First Drill Results from 2025 Program and Highlights 44 Metres of 2.81 G/T Gold and 0.66% Copper
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Revival Gold Intersects 1.04 g/t Gold Over 19.8 Meters & 0.85 g/t Gold Over 21.3 Meters in Shallow Drilling at Mercur
Onco360® Has Been Selected as a Specialty Pharmacy Partner for INLURIYO™ (imlunestrant)
Verde AgriTech Announces District Scale High-Grade Magnetic Rare Earths Discovery in Minas Gerais, Brazil
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
Eccogene Receives U.S. FDA Clearance to Initiate Phase 2a MOSAIC Trial of ECC4703 and ECC0509 for MASH
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions